Scent-Sational Advancement in Canine Research!

Bar-Ilan University study reveals insights into dogs’ olfactory systems that could pave the way for new applications in law enforcement, healthcare, and rescue operations

A pioneering study investigating the brain activity of dogs during scent detection has unveiled crucial insights into their remarkable olfactory capabilities. Researchers at Bar-Ilan University in Israel have developed an optical sensor capable of remotely sensing dogs’ brain activity in three key regions— the olfactory bulb, hippocampus, and amygdala— that play a critical role in how dogs distinguish between different smells. This breakthrough could lead to the development of a compact, non-invasive device capable of interpreting and translating a dog’s olfactory perceptions for human understanding. In the study, scientists employed a cutting-edge detection structure system using laser technology and a high-resolution camera to capture brain activity in real-time from four dog breeds. These dogs were exposed to four distinct scent stimuli—garlic, menthol, alcohol, and marijuana. The data were then analyzed using a machine-learning algorithm revealing that the amygdala plays a significant role in scent differentiation, highlighting the emotional and memory-related aspects of odor processing.

Full Story

Human Chromosomes Evolved at Hyperspeed to Give Us Better Brains

A study of artificial human and chimpanzee nerve cells revealed how faster-evolving DNA gives neurons the ability to build increasingly complex brain power.

How did humans evolve brains capable of complex language, civilization, and more? The answer could lie in exceptional DNA. Scientists at UC San Francisco found that parts of our chromosomes have evolved at breakneck speeds to give us an edge in brain development compared to apes. But it might also put us at risk for uniquely human brain disorders. The study, which was supported by grants from the National Institutes of Health, appeared in Nature on February 26, 2025. The article is titled “Comparative Characterization of Human Accelerated Regions in Neurons.”

Full Story

Reduction of Chemotherapy-Associated Accelerated Aging by ImmortaSome™ Personalized Exosome Rejuvenation

Immorta Bio announces proof-of-concept findings leveraging natural nanoparticles to rejuvenate damaged tissue

On March 10, 2025, Immorta Bio Inc, a Scientific Longevity Company dedicated to “Treating Diseases of Aging and Aging as Disease™” announced filing of a patent application covering its ImmortaSome™ personalized exosome technology. Laboratory and animal studies have shown that administration of ImmortaSome™ exosomes results in reduction of cellular aging in response to agents that normally accelerate aging such as chemotherapy. ImmortaSome exosomes are generated in a patient-specific manner in that patient blood is extracted, converted into Immortal Stem Cells called “Personal Regenerative Cells” (PRC).  The PRC are grown in the laboratory and converted to mesenchymal stem cells of a defined biological age, which are utilized as the source of the ImmortaSome™ exosomes.

Full Story